scorecardresearch
Saturday, November 2, 2024
TopicCovid vaccines

Topic: Covid vaccines

In leg-up to vaccination, SII’s Covovax on CoWin as heterologous booster, to cost Rs 225

Amid rising infection, SII had sought the inclusion of Covovax as a heterologous booster on the CoWin web portal last week.

11% of 69 crore eligible people have taken Covid precaution dose, says govt, blames waning fear

Slight rise in precaution dose coverage after vaccines were made free but govt officials cite ‘Covid surge in many countries’ to emphasise need to increase uptake.

BA.2.75 — new Covid variant detected in India a mystery, but could ‘have immune-escape property’

This Omicron sub-lineage may have increased ability to infect people who’ve been infected before, or are vaccinated, according to some scientists. However, there's no govt data on this.

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Our take on WHO’s Covid deaths estimate, RBI rate hike, SC’s vaccine take — in 50 words

ThePrint view on the most important issues this week.

2nd Covid shot from Serum Institute, Rs 225/dose: All about Covovax, new jab approved for teens

Covovax, developed by US company Novavax & manufactured in India by Serum Institute, is a protein-based vaccine developed from SARS-CoV-2 strain.

The ZyCoV-D mystery: 3 months after arrival in Bihar, not a single Covid vaccine shot given

Covid vaccine developed by Zydus Lifesciences was approved for use in those aged 12 and above in September 2021. Centre ordered 1 crore doses last year & delivery began in February.

We can’t ‘boost’ our way out of the Covid pandemic for the long term

While the vaccine is effective at preventing severe disease, it is likely that boosters will become an annual shot. Here's the science behind it.

New Covid vaccine developed in Germany produces better immune response in cancer patients

Peptide-based vaccine CoVac-1 has been developed by researchers at University of Tübingen. They say it induces better T-cell immune response in immunocompromised patients.

Now, data proves Covid vaccines work. So trust science, make third dose easily accessible

ThePrint view on the most important issues, instantly.

On Camera

Bibek Debroy was an ‘Acharya’ in India’s intellectual history

In the centuries to come, economist Bibek Debroy's Mahabharata will attain the importance we attach to the texts of Shankara, Ramanuja, and Madhvacharya.

Watch CutTheClutter: Flattening INR-USD rate, and debate on pros and cons of a ‘strong’ rupee

In Episode 1544 of CutTheClutter, Editor-in-Chief Shekhar Gupta looks at some top economists pointing to the pitfalls of ‘currency nationalism’ with data from 1991 to 2004.

All about Major Bob Khathing, whose daring expedition & diplomatic parleys secured Tawang for India

The decorated Naga officer from Manipur also served as envoy to Myanmar & Nagaland chief secy. Defence Minister Rajnath Singh inaugurated a museum dedicated to the Tawang hero Thursday.

From 2004 to 2024, bad news has come wrapped as good news for Congress

Congress is silently acknowledging it over-read verdict of last general election. You can see it in easy concession to SP. It will likely be more reasonable in Maharashtra & Jharkhand.